Treatment of metastatic colorectal cancer in a 44‑year‑old woman with internal comorbidities – a case report

03/2021

MUDr. Věra Benešová

Komplexní onkologické centrum, Nemocnice Jihlava

SUMMARY

In this case report, I describe the course of treatment of metastatic colorectal cancer in a 44-year-old woman with type 1 diabetes mellitus with insulin therapy and hypertension. The decision on the treatment sequence respected the current recommendations for the treatment of metastatic colorectal cancer, namely: examination in a multidisciplinary team, determination of the genetic type of the tumor, placement of the tumor and the overall lineage of the patient. Because the tumor was KRAS, NRAS wild-type, multiple liver lesions have been found in both lobes and it was left-sided cancer, systemic chemotherapy FOLFOX6 in combination with an epidermal growth factor receptor inhibitor, panitumumab (Vectibix inj.), has been chosen.

Key words

metastatic colorectal cancer, FOLFOX6 systemic chemotherapy, panitumumab